Skip to main content
. 2011 Sep 28;3:45–52. doi: 10.1007/8904_2011_47

Fig. 1.

Fig. 1

CSF T-tau and miglustat treatment. Follow-up sample was the next collected consecutive sample after basal sample. At baseline, patients starting treatment (a) had higher T-tau than patients without treatment (b) (p = 0.047) and patients with continuous treatment (c) (p = 0.018), but there was no significant difference between patients without treatment and patients on continuous treatment